According to the Huaxin Securities Research Report, Lotus Health (600186.SH) plans to acquire no less than 50% of Weizhili's shares to speed up the pace of overseas deployment and help expand the company's brand influence. The bank is optimistic that since the majority shareholder joined the company, it will continue to carry out internal reforms, resolve the burden of history, go to battle lightly, and actively develop a second growth curve. Maintain a “buy” investment rating.
研报掘金丨华鑫证券：莲花健康收购味之力加快海外布局，维持“买入”评级
Research Nuggets丨Huaxin Securities: Lotus Health Acquires WeizhiLi to Accelerate Overseas Expansion and Maintain a “Buy” Rating
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.